# Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage

Study · id `cardio:ct-nct01832389` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01832389](<https://clinicaltrials.gov/study/NCT01832389>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT01832389

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 108 participants.

## Technical summary

Registry record NCT01832389. Randomized; no masking; primary purpose treatment. Start 2013-03 (registry gives no type); primary completion 2015-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 108 participants (enrolled count; ClinicalTrials.gov record NCT01832389, source copy `cardio:ctgov-nct01832389-2019-03-13`, retrieved 2026-10-31)
- Start date: 2013-03 (registry gives no type) (ClinicalTrials.gov record NCT01832389, source copy `cardio:ctgov-nct01832389-2019-03-13`, retrieved 2026-10-31)
- Primary completion: 2015-11 (actual) (ClinicalTrials.gov record NCT01832389, source copy `cardio:ctgov-nct01832389-2019-03-13`, retrieved 2026-10-31)
- Completion: 2016-12 (actual) (ClinicalTrials.gov record NCT01832389, source copy `cardio:ctgov-nct01832389-2019-03-13`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT01832389, source copy `cardio:ctgov-nct01832389-2019-03-13`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01832389-2019-03-13`, retrieved 2026-10-31)

## The registry's words

- Brief title: Goal Directed Therapy After Aneurysmal Subarachnoid Haemorrhage
- Acronym: PiSAH
- Condition: Aneurysmal Subarachnoid Haemorrhage
- Condition: SAH
- Intervention (Device): PiCCO
- Lead sponsor: Technical University of Munich
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Subarachnoid hemorrhage (`cardio:subarachnoid-hemorrhage`)
- Registry lists this organization as the lead sponsor: Technical University of Munich (`cardio:org-technical-university-of-munich`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Impact of Goal-Directed Therapy on Delayed Ischemia After Aneurysmal Subarachnoid Hemorrhage: Randomized Controlled Trial (`cardio:pubmed-32640940`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 0847bc024947857ecb0b6e49988198298efb72a627c838f950936dd2b83a11e5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
